Facebook has hired David Ebersman as chief financial officer (CFO), effective as of September 2009. Ebersman was formerly executive vice president and CFO of Genentech, the pioneering biotechnology firm recently acquired by Roche.
Ebersman will report to chief executive officer (CEO) and founder Mark Zuckerberg. He will oversee Facebook’s finance, accounting, investor relations, and real estate functions. He also becomes a part of the company’s executive management team, which directs all aspects of company strategy, planning and operations.
Ebersman worked at Genentech for nearly 15 years. He served as the firm’s executive vice president and CFO from 2006 through April 2009, when Roche Group acquired the company. Prior to joining the company’s finance organisation, he was senior vice president of product operations. He joined Genentech as a business development analyst. Previously, he was a research analyst at Oppenheimer & Company.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.